H.R. 8983: Practitioner Enforcement and Tracking of Substances Act
The Practitioner Enforcement and Tracking of Substances Act (PETS Act) aims to enhance compliance among veterinarians regarding the reporting requirements for prescription drug monitoring programs (PDMPs). The main points of the bill include:
1. Compliance Requirements for Veterinarians
The bill amends existing laws to clarify that veterinarians must adhere to the same reporting obligations as other practitioners when prescribing controlled substances. Specifically:
- The law will require veterinarians to consult the PDMP before prescribing controlled substances.
- When dispensing controlled substances to a veterinary patient, veterinarians will need to report to the PDMP information related to the owner or primary caretaker of the patient instead of the pet’s details.
2. Reporting Non-Fatal Overdose Events
The bill introduces a requirement for any prescribing or dispensing practitioner to report instances of non-fatal overdoses that required intervention. Key details include:
- These reports must be submitted to the PDMP within 72 hours of the overdose event occurring.
3. Strengthening Language on Drug Misuse and Abuse
The bill will modify existing language regarding drug misuse and abuse, changing it from a permissive to a mandatory stance, which indicates that practitioners must take specific actions regarding suspected drug misuse or abuse.
4. Additional Definitions
With regard to the definition of a "dispenser," the bill adds veterinarians to the existing list, thereby recognizing their role in the dispensing of controlled substances.
5. Sense of Congress Statement
The bill expresses the notion that veterinarians are required to comply with PDMP requirements, regardless of state laws, emphasizing the importance of reporting and consulting protocols before prescribing controlled substances.
Relevant Companies
- None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| May. 21, 2026 | Introduced in House |
| May. 21, 2026 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.